Literature DB >> 33678172

A hidden cause of oxalate nephropathy: a case report.

Tala Mahmoud1, Elias C Ghandour2,3, Bernard G Jaar4,5,6,7.   

Abstract

BACKGROUND: Oxalate nephropathy is a rare disorder that can result in acute kidney injury (AKI) and progresses to end-stage kidney disease (ESKD). The causes can be either primary or secondary. Primary hyperoxaluria includes a group of hereditary disorders with enzymatic defects in the glyoxylate pathway, resulting in decreased oxalate metabolism. Secondary hyperoxaluria, often overlooked can result from increased intestinal absorption, nutritional deficiencies, decreased fluid intake, impaired excretion, and increased dietary consumption of oxalate. CASE
PRESENTATION: We present a Caucasian case of acute oxalate induced nephropathy associated with consumption of large quantities of green vegetables in a patient with chronic kidney disease (CKD). Imaging study showed no evidence of kidney stone, but a kidney biopsy revealed acute tubular injury, tubular atrophy, interstitial fibrosis, and dense tubular deposition of calcium oxalate crystals. Upon further questioning the patient, we learned that in the months prior to presentation, he had very significantly increased his consumption of green vegetables. Because of no clinical improvement, the patient was initiated and maintained on hemodialysis.
CONCLUSION: This report illustrates a case of acute oxalate nephropathy in the setting of very high dietary consumption of oxalate-rich foods in a patient with advanced CKD. Special attention should be given to the secondary causes of hyperoxaluria in patients with predisposing conditions such as CKD.

Entities:  

Keywords:  Acute kidney injury; Chronic kidney disease; Diet; End-stage kidney disease; Hyperoxaluria; Nephrolithiasis; Oxalate; Oxalosis; Vegetables

Mesh:

Substances:

Year:  2021        PMID: 33678172      PMCID: PMC7938566          DOI: 10.1186/s13256-021-02732-6

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  37 in total

1.  International registry for primary hyperoxaluria.

Authors:  John C Lieske; Carla G Monico; W Scott Holmes; Erik J Bergstralh; Jeffrey M Slezak; Audrey L Rohlinger; Julie B Olson; Dawn S Milliner
Journal:  Am J Nephrol       Date:  2005-06-15       Impact factor: 3.754

Review 2.  Enteric hyperoxaluria and renal failure associated with lymphangiectasia.

Authors:  A Allen; E Clutterbuck; G Maidment; E Thompson; R Watts; C Pusey
Journal:  Nephrol Dial Transplant       Date:  1997-04       Impact factor: 5.992

3.  Oxalate nephropathy associated with chronic pancreatitis.

Authors:  Claire Cartery; Stanislas Faguer; Alexandre Karras; Olivier Cointault; Louis Buscail; Anne Modesto; David Ribes; Lionel Rostaing; Dominique Chauveau; Patrick Giraud
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

4.  Orlistat-induced oxalate nephropathy may be dose-independent and present as a late manifestation.

Authors:  Neville R Dossabhoy; Scott McRight; Bhupinder Sangha; Sarah Khan; Cherinet Adgeh
Journal:  J La State Med Soc       Date:  2013 Sep-Oct

5.  Plasma oxalate concentration and renal excretion of oxalate in man.

Authors:  A Hodgkinson; R Wilkinson
Journal:  Clin Sci Mol Med       Date:  1974-01

6.  Oxalate content of foods and its effect on humans.

Authors:  S C Noonan; G P Savage
Journal:  Asia Pac J Clin Nutr       Date:  1999-03       Impact factor: 1.662

Review 7.  An update on primary hyperoxaluria.

Authors:  Bernd Hoppe
Journal:  Nat Rev Nephrol       Date:  2012-06-12       Impact factor: 28.314

8.  Dietary oxalate and calcium oxalate nephrolithiasis.

Authors:  Saeed R Khan; Patricia A Glenton; Karen J Byer
Journal:  J Urol       Date:  2007-09-17       Impact factor: 7.450

Review 9.  The association of nephrolithiasis with cystic fibrosis.

Authors:  Eric M Gibney; David S Goldfarb
Journal:  Am J Kidney Dis       Date:  2003-07       Impact factor: 8.860

10.  Determinants of urolithiasis in patients with intestinal fat malabsorption.

Authors:  Roswitha Siener; Julia Petzold; Norman Bitterlich; Birgit Alteheld; Christine Metzner
Journal:  Urology       Date:  2012-11-30       Impact factor: 2.649

View more
  1 in total

1.  Design and Synthesis of New Pyrimidine-Quinolone Hybrids as Novel hLDHA Inhibitors.

Authors:  Iván Díaz; Sofia Salido; Manuel Nogueras; Justo Cobo
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.